+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Molecular targets in drugs discovery in idiopathic pulmonary fibrosis. Work in progress



Molecular targets in drugs discovery in idiopathic pulmonary fibrosis. Work in progress



American Journal of Respiratory Cell and Molecular Biology 29(3 Suppl.): S98-101




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 049618748

Download citation: RISBibTeXText

PMID: 14503565


Related references

Molecular targets for drug discovery in idiopathic pulmonary fibrosis: Work in progress. American Journal of Respiratory Cell and Molecular Biology 29(3 Part 2): S98-S101, 2003

Exploitation of Novel Molecular Targets to Treat Idiopathic Pulmonary Fibrosis: A Drug Discovery Perspective. Current Medicinal Chemistry 24(22): 2439-2458, 2017

Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets. Journal of Medicinal Chemistry 60(2): 527-553, 2017

Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets. International Journal of Molecular Sciences 20(3), 2019

Progress in the discovery of naturally occurring anti-diabetic drugs and in the identification of their molecular targets. Fitoterapia 2019, 2019

Progress of treating idiopathic pulmonary interstitial fibrosis by single Chinese drugs and their derivatives. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 33(3): 420-424, 2014

Recent Advances in Molecular Targets and Treatment of Idiopathic Pulmonary Fibrosis: Focus on Tgf Signaling and the Myofibroblast. Current Medicinal Chemistry 16(11): 1400-1417, 2009

Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast. Current Medicinal Chemistry 16(11): 1400-1417, 2009

Novel drug targets for idiopathic pulmonary fibrosis. Expert Review of Respiratory Medicine 2016: 1-13, 2016

Therapeutic targets in idiopathic pulmonary fibrosis. Respiratory Medicine 131: 49-57, 2018

Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress. International Journal of Immunopathology and Pharmacology 25(3): 681-689, 2012

Research progress in pulmonary microecology of idiopathic pulmonary fibrosis. Zhonghua Jie He He Hu Xi Za Zhi 41(3): 231-233, 2018

Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis. Pulmonary Pharmacology and Therapeutics 20(5): 453-461, 2006

Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis. American Journal of Respiratory Cell and Molecular Biology 53(5): 585-600, 2016

Idiopathic pulmonary fibrosis -- progress in sight. Duodecim; Laaketieteellinen Aikakauskirja 127(24): 2639-2645, 2012